Mostrar el registro sencillo del ítem

dc.contributor.authorLazarus, Jeffrey V
dc.contributor.authorOrtiz, Alberto
dc.contributor.authorTyrovolas, Stefanos
dc.contributor.authorFernández, Esteve
dc.contributor.authorGuy, Danielle
dc.contributor.authorWhite, Trenton M
dc.contributor.authorMa, Rui
dc.contributor.authorHay, Simon I
dc.contributor.authorNaghavi, Mohsen
dc.contributor.authorSoriano, Joan B
dc.contributor.authorThe GBD 2019 Spain Collaborators
dc.contributor.authorPadron-Monedero, Alicia 
dc.date.accessioned2023-04-24T11:03:27Z
dc.date.available2023-04-24T11:03:27Z
dc.date.issued2022-12-07
dc.identifier.citationSci Rep. 2022 Dec 7;12(1):21154.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15876
dc.description.abstractThis study aimed to report mortality, risk factors, and burden of diseases in Spain. The Global Burden of Disease, Injuries, and Risk Factors 2019 estimates the burden due to 369 diseases, injuries, and impairments and 87 risk factors and risk factor combinations. Here, we detail the updated Spain 1990-2019 burden of disease estimates and project certain metrics up to 2030. In 2019, leading causes of death were ischaemic heart disease, stroke, chronic obstructive pulmonary disease, Alzheimer's disease, and lung cancer. Main causes of disability adjusted life years (DALYs) were ischaemic heart disease, diabetes, lung cancer, low back pain, and stroke. Leading DALYs risk factors included smoking, high body mass index, and high fasting plasma glucose. Spain scored 74/100 among all health-related Sustainable Development Goals (SDGs) indicators, ranking 20 of 195 countries and territories. We forecasted that by 2030, Spain would outpace Japan, the United States, and the European Union. Behavioural risk factors, such as smoking and poor diet, and environmental factors added a significant burden to the Spanish population's health in 2019. Monitoring these trends, particularly in light of COVID-19, is essential to prioritise interventions that will reduce the future burden of disease to meet population health and SDG commitments.es_ES
dc.description.sponsorshipThe GBD Study is funded by the Bill and Melinda Gates foundation. J.V.L., D.G., and T.M.W. acknowledge support to ISGlobal from the Spanish Ministry of Science, Innovation and Universities through the "Centro de Excelencia Severo Ochoa 2019-2023" Programme (CEX2018-000806-S), and from the Government of Catalonia, Spain, through the CERCA Programme. J.L.A-M. was funded by the Instituto de Salud Carlos III (Grant Number PI19/00150). I.G-V. was supported by the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. A.O. was funded by the Instituto de Salud Carlos III (ISCIII) RICORS program to RICORS2040 (RD21/0005/0001), European Union—NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (MRR) and SPACKDc PMP21/00109, and FEDER. E.F. is partly supported by the Ministry of Universities and Research, Government of Catalonia (2017SGR319) and receives institutional support from IDIBELL. R.T-S. is supported by the Spanish Ministry of Science and Innovation, Institute of Health Carlos III, and INCLIVA (PID2021-129099OB-I00).es_ES
dc.language.isoenges_ES
dc.publisherNature Publishing Group es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshCOVID-19es_ES
dc.subject.meshMyocardial Ischemia es_ES
dc.subject.meshLung Neoplasms es_ES
dc.subject.meshHumans es_ES
dc.subject.meshSustainable Development es_ES
dc.subject.meshSpain es_ES
dc.titleA GBD 2019 study of health and Sustainable Development Goal gains and forecasts to 2030 in Spaines_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID36477107es_ES
dc.format.volume12es_ES
dc.format.number1es_ES
dc.format.page21154es_ES
dc.identifier.doi10.1038/s41598-022-24719-zes_ES
dc.contributor.funderBill & Melinda Gates Foundation es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) es_ES
dc.contributor.funderGovernment of Catalonia (España) es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) es_ES
dc.contributor.funderMinisterio de Universidades (España) es_ES
dc.contributor.funderInstituto de Investigación Biomédica de Bellvitge (España)es_ES
dc.contributor.funderInstituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia (España)es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2045-2322es_ES
dc.relation.publisherversionhttps://doi.org/10.1038/s41598-022-24719-zes_ES
dc.identifier.journalScientific reportses_ES
dc.repisalud.centroISCIII::Escuela Nacional de Sanidades_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PMP21%2F00109/ES/SPAIN CKD CAUSE (SPACKDC)/ es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CEX2018-000806-Ses_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/Subprograma Estatal de Generación de Conocimiento/PI19 - Proyectos de investigacion en salud (AES 2019). Modalidad proyectos en salud. (2019)/PI19/00150es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/RD21/0005/0001es_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional